Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amman Mineral Internasional Tbk (AMMN) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Amman Mineral Internasional Tbk
Diagnos Laboratorium Utama Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Amman Mineral Internasional Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Amman Mineral Internasional Tbk trades at Rp3,350 (market cap 258.16T, 72.41M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 1.74M 24h volume). The key difference: Amman Mineral Internasional Tbk is far larger — about 809.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Amman Mineral Internasional Tbk is more actively traded (72.41M versus 1.74M). Which is the better fit depends on your goals.

AMMNDGNS
Market Cap
258.16T319B
Volume
72.41M1.74M
Lot
724.15K17.44K
Turnover
248.17B400.92M
Average Price
3,427.09229.87
Value
248.17B400.92M
Indicative Equilibrium Price
3,350232
Indicative Equilibrium Volume
29.86K212

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AMMN
View details
DGNS
View details

About Amman Mineral Internasional Tbk

PT Amman Mineral Internasional Tbk (the Company) was established on September 29, 2015 under the name PT Amman Mineral Internasional and based on Notarial Deed No. 30 of Martina, S.H., notary in Jakarta. The Company was established in connection with the acquisition of AMNT, formerly known as PT Newmont Nusa Tenggara (PTNNT). PTNNT runs its operations under the ownership of a consortium of investors, including Nusa Tenggara Partnership B.V. (NTPBV) which is indirectly owned by Newmont Corporation (Newmont) and Sumitomo Corporation (Sumitomo), PT Multi Daerah Bersaing (PTMDB), PT Indonesia Masbaga Investama (PTIMI), and PT Pukuafu Indah (PTPI). On November 2, 2016, the Company acquired 82.2% shares of PTNNT from NTPBV, PTMDB, and PTIMI, and changed PTNNTs name to AMNT (Acquisition). In December 2020, the Company acquired the remaining outstanding shares of AMNT from PTPI, where the Company is until the date of this Prospectus is issued, owns 99.99% of AMNTs outstanding shares. The remaining 0.01% outstanding shares of AMNT are owned by PT AP Investment (PTAPI), one of the Companys shareholders. Established in 1986, PTNNT began development and construction of the Batu Hijau mine in 1997 and has been producing commodities in the form of copper concentrate which also contains gold and silver as minerals followers since 2000.

Read more on AMMN

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS